Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Latest action · Sep 20, 2023 Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 7, 2023
- Passed HouseJul 17, 2023
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.
The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).
Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Mar 7, 2023 to Jun 6, 2023; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-WA | Kim Schrier | Original | Mar 7, 2023 |
| D-NV | Susie Lee | Jun 6, 2023 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 7, 2023Markup May 24, 2023Reported Jun 9, 2023 |
| Health Subcommittee | Referred Mar 17, 2023Markup May 17, 2023Reported May 17, 2023 |
Actions 16
Everything that happened, newest first.
- Sep 20, 2023Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
- Jul 18, 2023Received in the Senate.
- Jul 17, 2023Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
- Jul 17, 2023Considered under suspension of the rules. (consideration: CR H3620-3624)
- Jul 17, 2023DEBATE - The House proceeded with forty minutes of debate on H.R. 1418.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H3620–H3624Text printed H3620–H3623 | Greg Pence R-IN, Gus M. Bilirakis R-FL, Kim Schrier D-WA, Sheila Jackson Lee D-TX | Jul 17, 2023 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 43, March 7, 2023, page H1152.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1844 | Animal Drug and Animal Generic Drug User Fee Amendments of 2023 | Related bill | Jul 26, 2023 |
| HR 5860 | Continuing Appropriations Act, 2024 and Other Extensions Act | Related bill | Sep 30, 2023 |
Titles 13
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.
- Short Title(s) as Introduced
- Animal Drug User Fee Amendments of 2023
- Short Title(s) as Reported to House
- Animal Drug and Animal Generic Drug User Fee Amendments of 2023
- Short Title(s) as Passed House
- Animal Drug and Animal Generic Drug User Fee Amendments of 2023
- Short Title(s) as Introduced for portions of this bill
- Animal Drug User Fee Amendments of 2023
- Animal Generic Drug User Fee Amendments of 2023
- Short Title(s) as Reported to House for portions of this bill
- Animal Generic Drug User Fee Amendments of 2023
- Animal Drug User Fee Amendments of 2023
- Short Title(s) as Passed House for portions of this bill
- Animal Drug User Fee Amendments of 2023
- Animal Generic Drug User Fee Amendments of 2023
- Short Titles for portions of this bill from PCS (Placed on Senate Calendar) bill text
- Animal Drug User Fee Amendments of 2023
- Animal Generic Drug User Fee Amendments of 2023
- Short Title(s) from PCS (Placed on Senate Calendar) bill text
- Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Sep 20, 2023Placed on Calendar Senate
- Jul 17, 2023Engrossed in House
- Jun 9, 2023Reported in House
- Mar 7, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.